Insu Therapeutics Overview
- Year Founded
-
2018
- Status
-
Private
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$220K
- Investors
-
2
Insu Therapeutics General Information
Description
Developer of a buccal drug delivery platform designed to transform injectable peptide medications into oral tablets. The company's platform utilizes mucoadhesive tablets and a mucosal absorption technology to deliver insulin and glucagon-like peptide-1 medications through the oral cavity, bypassing the gastrointestinal tract and liver metabolism issues, enabling diabetic patients to manage chronic conditions without needle injections, refrigeration requirements, or gastrointestinal degradation.
Contact Information
Website
www.insutherapeutics.caCorporate Office
- Vancouver, British Columbia
- Canada
Corporate Office
- Vancouver, British Columbia
- Canada
Insu Therapeutics Timeline
Insu Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC | 06-Mar-2026 | $220K | Completed | Generating Revenue | ||
| 2. Later Stage VC | 01-Jan-2024 | Completed | Generating Revenue | |||
| 1. University Spin-Out | 19-Oct-2018 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Insu Therapeutics Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Victory Square Technologies | Venture Capital | Minority | ||
| The University of British Columbia | University |
Insu Therapeutics FAQs
-
When was Insu Therapeutics founded?
Insu Therapeutics was founded in 2018.
-
Where is Insu Therapeutics headquartered?
Insu Therapeutics is headquartered in Vancouver, Canada.
-
What industry is Insu Therapeutics in?
Insu Therapeutics’s primary industry is Drug Delivery.
-
Is Insu Therapeutics a private or public company?
Insu Therapeutics is a Private company.
-
What is Insu Therapeutics’s current revenue?
The current revenue for Insu Therapeutics is .
-
How much funding has Insu Therapeutics raised over time?
Insu Therapeutics has raised $220K.
-
Who are Insu Therapeutics’s investors?
Victory Square Technologies and The University of British Columbia have invested in Insu Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process